ArticleACS central science2024

Engineering a SARS-CoV-2 Vaccine Targeting the Receptor-Binding Domain Cryptic-Face via Immunofocusing.

Theodora U J Bruun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.